U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H37ClN4O.2ClH.H2O
Molecular Weight 572.01
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOCAPRAMINE DIHYDROCHLORIDE MONOHYDRATE

SMILES

O.Cl.Cl.NC(=O)C1(CCN(CCCN2C3=CC=CC=C3CCC4=C2C=C(Cl)C=C4)CC1)N5CCCCC5

InChI

InChIKey=SWCNPPOGIXOVAZ-UHFFFAOYSA-N
InChI=1S/C28H37ClN4O.2ClH.H2O/c29-24-12-11-23-10-9-22-7-2-3-8-25(22)33(26(23)21-24)18-6-15-31-19-13-28(14-20-31,27(30)34)32-16-4-1-5-17-32;;;/h2-3,7-8,11-12,21H,1,4-6,9-10,13-20H2,(H2,30,34);2*1H;1H2

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C28H37ClN4O
Molecular Weight 481.073
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://www.kegg.jp/medicus-bin/japic_med_product?id=00048317-003 | http://en.pharmacodia.com/web/drug/1_10640.html

Clocapramine is a chlorinated derivative of carpipramine. The hydrochloride has been given orally in the treatment of schizophrenia. Clocapramine is an antagonist of the Dopamine D2 and Serotonine (5-HT2) receptors. It has been implicated in at least one strange death, including a suicide. It augments the paroxetine in the panic disorder treatment.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
13.0 nM [Ki]
1.9 nM [Ki]
1.5 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CLOFEKTON

Approved Use

Clofekton 10% is indicated for the treatment of schizophrenia.

Launch Date

1974
PubMed

PubMed

TitleDatePubMed
Clocapramine-related fatality. Postmortem drug levels in multiple psychoactive drug poisoning.
2001 Oct 15
Patents

Sample Use Guides

30 to 150 mg daily in three divided doses
Route of Administration: Oral
In Vitro Use Guide
Various concentrations of clocapramine was applied to NCB20 cells and reward currents were recorded. The cells were voltage-clamped at -60 mV. The compositions of internal and external solutions were both normal. Concentration-response curves for each compound were obtained from 6 to 10 cell. The Hill coefficients of clocapramine was 0.79. The Ka values for these compounds was 1.1 uM.
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:35:27 GMT 2023
Edited
by admin
on Fri Dec 15 17:35:27 GMT 2023
Record UNII
9NLU6H3LRD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOCAPRAMINE DIHYDROCHLORIDE MONOHYDRATE
MI  
Common Name English
1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)(1,4'-BIPIPERIDINE)-4'-CARBOXAMIDE DIHYDROCHLORIDE MONOHYDRATE
Systematic Name English
CLOCAPRAMINE HYDROCHLORIDE [MART.]
Common Name English
CLOCAPRAMINE HCL
Common Name English
CLOCAPRAMINE HYDROCHLORIDE
MART.  
Common Name English
Y-4153
Code English
(1,4'-BIPIPERIDINE)-4-CARBOXAMIDE, 1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)-, HYDROCHLORIDE, HYDRATE (1:2:1)
Systematic Name English
CLOCAPRAMINE HYDROCHLORIDE HYDRATE [JAN]
Common Name English
CLOFEKTON
Brand Name English
CLOCAPRAMINE DIHYDROCHLORIDE MONOHYDRATE [MI]
Common Name English
Y 4153
Code English
Code System Code Type Description
EVMPD
SUB01349MIG
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
CAS
60789-62-0
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
PUBCHEM
5282503
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
SMS_ID
300000022031
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
FDA UNII
9NLU6H3LRD
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
MERCK INDEX
m3631
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY Merck Index
DRUG BANK
DBSALT002792
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104103
Created by admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY